Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-368-7 | CAS number: 81-64-1
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Several in vitro assays (Ames tests, a chromosome aberration test, a
HGPRT assay, 2 SCE assays and several UDS/DNA repair assays) are
published. Additionally an in-vitro micronuleus test in chinese hamster
V79 cells according to OECD TG 487 was conducted.
No in vivo assay is available.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
No in vivo assay is available.
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In the Ames test, 1,4-dihydroxyanthraquinoe was positive (with the exception of those assays were only a limited number of S. typhimurium strains were used. 1,4-dihydroxyanthraquinone was also positive in the CA test and the in-vitro micronucleus test in Chinese hamster V79 cells.
In the HGPRT test and the UDS/DNA repair assays, 1,4-dihydroxyanthraquinone was negative, also in the genotoxicity assay in Saccharomyces cervesia. In the SCE assay, 1,4-dihydroxyanthraquinone revealed a weak (and dose independent) effect.
In 2 in vitro DNA binding assays a positive and a negative result was obtained (see section 7.9.3 specific investigations).
Justification for classification or non-classification
In the Ames tests, the chromosome aberration test and the in-vitro MNT a positive result was obtainded. In the HGPRT test and the UDS/DNA repair assays, 1,4-dihydroxyanthraquinone was negative, also in the genotoxicity assay in Saccharomyces cervesia. In the SCE assay, 1,4-dihydroxyanthraquinone revealed a weak (and dose independent) effect.
In 2 in vitro DNA binding assays a positive and a negative result was obtained (see section 7.9.3 specific investigations).
Overall, 1,4-dihydroxyanthraquinone was positive in several in-vitro assays, but no in-vivo studies are available. Based on the inconclusive results a classification according to CLP classification criteria (Regulation (EC) No 1272/2008) is not suitable, however due to the ambigouos results 1,4-dihydroxyanthraquinone is allocated to the medium hazard band.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
